Slides
Page 1
Investor Deck – FY25 May 15, 2025
Page 2
Safe Harbour Certain statements in this release concerning Sagility’ future growth prospects may be seen as forward - looking statements, which involve a number of risks and uncertainties that could cause the actuals to differ materially from such statements. Sagility does not undertake to update any such statement that may have been made from time to time by or on behalf of the company.. 2
Page 3
Key Highlights ► FY25 Revenue at ₹55,699 million, grew by ₹8,164 million Y-o-Y (corresponding to 17.2% growth Y-o-Y and 14.9% at constant currency. ► Adjusted EBITDA (excl Other Income) at ₹14,685 million, grew by ₹3,249 million Y-o-Y (corresponding to 28.4% growth Y-o-Y ) ► Adjusted PAT at ₹8.107 million, grew by ₹ 2,211 million Y-o-Y (corresponding to 37.5% growth Y-o-Y ) ► Revenue in Q4 at ₹ 15,685 million grew by ₹2,853 million Y-o-Y (corresponding to 22.2% growth Y-o-Y and 17.7% at constant currency. ► Adjusted EBITDA (excl Other Income) at ₹4,042 million, grew by ₹899 million Y- o-Y (corresponding to 28.6% growth Y-o-Y ) ► Adjusted PAT at ₹2,398 million, grew by ₹747 million Y-o-Y (corresponding to 45.2% growth Y-o-Y ) ► FY25 concluded with robust year-on-year growth, largely fueled by our tenured existing clients and logos won over the last couple of years. Total Q-o-Q growth of 7.9% in INR and 5.7% in constant currency was fueled by acquisition of Broadpath in Q4. ► Together with tech- and transformation-led services—powered by automation, analytics, and GenAI, and our consulting services, we are gaining strong traction with clients, further enhancing our reputation as a trusted strategic and advisory partner. ► Recent acquisition of BroadPath has the potential to unlock additional opportunities in several mid-market clients of Broadpath ; targeted cross-sell initiatives planned for FY26 ► Operations remain robust, driven by strong performance across key metrics ► People: Global headcount stands at 39,409 as of Mar 2024. ► 4,365 employees added during FY25 (12.5% Y-o-Y growth in headcount); Attrition at 27.5%* ► Recognitions: Major Contender in the Everest Group Payment Integrity Solutions PEAK Matrix® Assessment 2025; Major Contender in Healthcare Payer Business Process as a Service (BPaaS) – Solutions PEAK Matrix® Assessment 2024 Key Business Highlights * Voluntary attrition considering employees who were employees for more than 90 days (%) on an annualized basis exclude BroadPath FY25 Highlights Q4 FY25 Highlights 3
Page 4
KPIs *considering employees who were employees for more than 90 days (%) on an annualized basis. **FY attrition rate exclude BroadPath 4 KPI Q4'25 Q3'25 Q4'24 YoY% FY'25 FY'24 YoY% Revenue from Operation (in INR Million) 15,685 14,531 12,832 22.2% 55,699 47,536 17.2% Revenue by Vertical Split By Payer % 89.7% 89.3% 90.8% 89.4% 90.3% By Provider % 10.3% 10.7% 9.2% 10.6% 9.7% Growth in revenue from operation (%) 22.2% 15.3% 17.2% 12.7% Adjusted EBITDA (in INR Million) 4,143 4,567 3,188 30.0% 15,248 11,715 30.2% Adjusted EBITDA % 26.4% 31.4% 24.8% 27.4% 24.6% Adjusted PAT (in INR Million) 2,398 2,626 1,651 45.2% 8,107 5,896 37.5% Adjusted PAT % 15.3% 18.1% 12.9% 14.6% 12.4% Total Number of Employees 39,409 39,595 35,044 12.5% 39,409 35,044 12.5% Voluntary attrition rate* (%) 32.5% 21.8% 30.4% 27.5% 27.2%**
Page 5
Annual KPI’s 5 KPI FY'25 FY'24 FY’23 Number of Client groups* Active 75 44 35 Number of new client addition (Gross) 38 13 7 Client groups contribution to revenues Top 3 Client % 66.2% 68.3% 72.4% Top 5 Client % 77.9% 79.2% 80.6% Top 10 Client % 90.5% 91.4% 90.7% Number of Million-dollar client groups Number of clients contributing more than US$20 million 7 5 4 Number of clients contributing to US$5 - US$20 million 6 7 7 Number of clients contributing to US$1 - US$5 million 12 12 12 Number of clients contributing less than US$1 million 50 20 12 Delivery sites Number of delivery sites 33 30 27 New site addition (Gross) 10 4 2 * Client groups comprise client entities together with their affiliates.
Page 6
Financial Highlights
Page 7
Highlights FY25 Financial Highlights ► FY25 revenue stood at ₹55,699 Million ($658.3 M) ► 17.2% growth Y-o-Y (14.9% at constant currency ) ► Adjusted EBITDA (excl OI) at ₹14,685 Million ($173.6 M) ► Adjusted EBITDA Margin : 26.4% ► 28.4% growth Y-o-Y ► Adjusted PAT at ₹8,107 Million ($95.8 M) ► Adjusted PAT Margin: 14.6% ► 37.5% growth Y-o-Y; ► OCF ₹12,141 Million ($ 143.5 M) ► 89.7% of EBITDA ► Q4’25 revenue stood at ₹15,685 Million ($181.8 M) ► 22.2% growth Y-o-Y (17.7% at constant currency ) ► 7.9% growth Q-o-Q (5.7% at constant currency) ► Adjusted EBITDA (excl OI) at ₹4,042 Million ($46.8 M) ► Adjusted EBITDA Margin : 25.8% ► 28.6% growth Y-o-Y; ► Adjusted PAT at ₹2,398 Million ($27.8 M) ► Adjusted PAT Margin : 15.3 % ► 45.2% growth Y-o-Y ► OCF ₹3,009 Million ($34.8 M) ► 78.5% of EBITDA Strong FY25 Performance Q4 FY25 Financial Highlights 7
Page 8
₹11.2 ₹10.9 ₹12.6 ₹12.8 12.8% 11.5% 12.4% 12.9% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% 40.0% ₹9.0 ₹10.0 ₹11.0 ₹12.0 ₹13.0 ₹14.0 ₹15.0 Q1 FY24 Q2 FY24 Q3 FY24 Q4 FY24 Revenue INR B Adjusted PAT % Quarter wise performance 33.5 * Q4 FY 25 Headcount includes BroadPath Headcount of 1,083 (acquired in Q4 FY25) FY 24 36.5 36.6 35.0 35.8 38.3 39.6 Headcount (‘000) Headcount (‘000) ₹12.2 ₹13.3 ₹14.5 ₹15.7 11.8% 12.3% 18.1% 15.3% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% 40.0% ₹9.0 ₹10.0 ₹11.0 ₹12.0 ₹13.0 ₹14.0 ₹15.0 ₹16.0 ₹17.0 Q1 FY25 Q2 FY25 Q3 FY25 Q4 FY25 Revenue INR B Adjusted PAT % FY 25 39.4*
Page 9
Financial performance snapshot – Long Term Revenue (INR Million) FY24 YoY% FY25 YoY% 12.7% 17.2% Adjusted EBITDA * (INR Million) FY24 YoY% FY25 YoY% 11.3% 28.4% Adjusted PAT (INR Million) FY24 YoY% FY25 YoY% 29.4% 37.5% Revenue ($M) FY24 YoY% FY25 YoY% 10.5% 14.9% Adjusted EBITDA* ($M) FY24 YoY% FY25 YoY% 9.2% 25.9% Adjusted PAT ($M) FY24 YoY% FY25 YoY% 27.0% 34.8% 9 ₹42,184 ₹47,536 ₹55,699 FY'23 FY'24 FY'25 ₹10,272 ₹11,436 ₹14,685 FY'23 FY'24 FY'25 ₹4,556 ₹5,896 ₹8,107 FY'23 FY'24 FY'25 $518.2 $572.9 $658.3 FY'23 FY'24 FY'25 $126.2 $137.8 $173.6 FY'23 FY'24 FY'25 $56.0 $71.1 $95.8 FY'23 FY'24 FY'25 *Adjusted EBITDA excluding other income
Page 10
Financial performance snapshot – Q4 FY25 Revenue (INR Million) Y-o-Y Q-o-Q 22.2% 7.9% Adjusted EBITDA* (INR Million) Y-o-Y Q-o-Q 28.6% -2.1% Adjusted PAT (INR Million) Y-o-Y Q-o-Q 45.2% -8.7% Revenue ($M) Y-o-Y Q-o-Q 17.7% 5.7% Adjusted EBITDA* ($M) Y-o-Y Q-o-Q 23.8% -4.2% Adjusted PAT ($M) Y-o-Y Q-o-Q 40.1% -10.6% 10 ₹12,832 ₹14,531 ₹15,685 Q4'24 Q3'25 Q4'25 ₹3,143 ₹4,127 ₹4,042 Q4'24 Q3'25 Q4'25 ₹1,651 ₹2,626 ₹2,398 Q4'24 Q3'25 Q4'25 $154.4 $172.0 $181.8 Q4'24 Q3'25 Q4'25 $37.8 $48.9 $46.8 Q4'24 Q3'25 Q4'25 $19.9 $31.1 $27.8 Q4'24 Q3'25 Q4'25 *Adjusted EBITDA excluding other income
Page 11
Financial Indicators Adjusted EPS is Adjusted PAT divided by weighted average number of equity shares Adjusted ROCE is Adjusted PAT plus Interest cost divided by capital employed (Assets excluding goodwill and intangibles asset s less current liabilities) Net Debt is Borrowing plus lease liabilities less Cash and Cash equivalent. Borrowing doesn’t include accrued interest 11 1.06 1.38 1.76 FY'23 FY'24 FY'25 Adjusted EPS (in INR) 41.6% 47.0% 54.9% FY'23 FY'24 FY'25 Adjusted ROCE % 82.0% 87.2% 89.7% 68.2% 70.8% 80.5% FY'23 FY'24 FY'25 Cash Conversion (%) OCF % FCF % ₹22,863 ₹21,678 ₹10,432 2.19x 1.85x 0.68x - 0.50 1.00 1.50 2.00 2.50 ₹0 ₹5,000 ₹10,000 ₹15,000 ₹20,000 ₹25,000 FY'23 FY'24 FY'25 Net Debt Net Debt (in INR Million) Net Debt to Adjusted EBITDA
Page 12
Q4 & FY25 Consolidated Financials Amt in INR M Particulars Q4 FY25 Q3 FY25 Q4 FY24 YoY% QoQ% FY25 FY24 YoY% Revenue from Operation 15,685 14,531 12,832 22.2% 7.9% 55,699 47,536 17.2% Other Income 101 440 46 563 279 Employee benefits expense 9,741 8,620 7,995 34,989 29,376 Other expenses 2,212 1,988 1,764 7,731 7,278 Reported EBITDA 3,832 4,362 3,119 22.9% -12.2% 13,542 11,160 21.3% Adjusted EBITDA 4,143 4,567 3,188 30.0% -9.3% 15,248 11,715 30.2% Adjusted EBITDA % 26.4% 31.4% 24.8% 27.4% 24.6% Adjusted EBITDA excl. other income 4,042 4,127 3,143 28.6% -2.1% 14,685 11,436 28.4% Adjusted EBITDA excl. other income % 25.8% 28.4% 24.5% 26.4% 24.1% Finance costs 298 302 429 1,271 1,851 Depreciation and amortisation expenses 1,143 1,162 1,760 4,669 6,892 Profit Before Tax 2,390 2,898 929 157.3% -17.5% 7,602 2,417 214.6% Tax Expenses 564 729 127 2,211 134 Reported Profit After Tax 1,826 2,169 802 127.6% -15.8% 5,391 2,283 136.2% EPS 0.39 0.46 0.19 108.5% -15.8% 1.17 0.53 119.3% Adjusted PAT 2,398 2,626 1,651 45.2% -8.7% 8,107 5,896 37.5% Adjusted PAT % 15.3% 18.1% 12.9% 14.6% 12.4% Adjusted EPS (Basic and Diluted) (Rs) 0.51 0.56 0.39 33.0% -8.7% 1.76 1.38 27.7% 12 ❖ Q4’25 Organic Revenue at INR 14,929 Mn (YoY% 16.3% and QoQ% 2.7%) ❖ FY’25 Organic Revenue at INR 54,943 Mn (YoY% 15.6%) ❖ Q4 Adj. EBITDA margin (excl. OI) is lower than Q3 due to (a) Change in revenue mix as BroadPath is onshore (b) Salary hikes made effective from Jan 25 ❖ Dip in Q4 Reported EBITDA margins due to above and lower other income and earnout for BroadPath ❖ Finance cost include interest cost on long-term borrowing from promoter and interest expenses on lease liabilities
Page 13
Adjustments on EBITDA and PAT Adj EBITDA Bridge: FY25Adj EBITDA Bridge: Q4 FY25 Adj A - Earnouts under acquisition agreements and for PAT it is adjusted for tax Adj B - Share based payment awards ( non cash expenses for the company and not tax deductible) Adj C - Intangible assets Amortization is amortization of intangible assets acquired pursuant to carveout of healthcare business from the seller Adj PAT Bridge: FY25Adj PAT Bridge: Q4 FY25 INR Million INR Million INR Million INR Million 13 ₹3,832 ₹207 ₹104 ₹4,143 Reported EBITDA Adj A Adj B Adjusted EBITDA ₹13,542 ₹571 ₹1,134 ₹15,248 Reported EBITDA Adj A Adj B Adjusted EBITDA ₹1,826 ₹151 ₹104 ₹317 ₹2,398 Reported PAT Adj A Adj B Adj C Adjusted PAT ₹5,391 ₹418 ₹1,134 ₹1,163 ₹8,107 Reported PAT Adj A Adj B Adj C Adjusted PAT
Page 14
Go Forward Positions • Numbers are based on the current visibility of management and are subject to change. Factors such as new loans, acquisitions, foreign exchange rate or changes in our share- based payment award plan could impact the final figures • Intangible Amortisation include amortization of intangible assets acquired pursuant to business combinations (includes DCI, Birch and BroadPath) 14 Amt in INR M Particulars FY'25 FY'26 FY'27 FY'28 FY'29 Closing Debt position 8,020 5,670 Debt Repayment 2,490 2,350 5,670 Interest Payment 751 535 285 Share based Payment awards 1,134 250 146 78 40 Earnouts Cost - DCI / Birch/ BroadPath 571 494 5 Intangibles Amortisation 1,588 1,795 1,785 1,771 1,698
Page 15
Balance Sheet as on 31st Mar’25 15 Amt in INR M Particulars Mar’25 Mar'24 Property, plant and equipment 3,699 3,832 Capital-work-in-progress 0 57 Right-of-use assets 5,521 5,665 Goodwill 60,390 57,096 Other intangible assets 20,362 20,078 Trade receivables and Unbilled 12,668 11,813 Cash and cash equivalents 3,438 3,441 Deferred tax assets (net) 1,337 1,354 Other Assets 3,091 3,305 Total Assets 110,507 106,642 Equity 83,361 64,431 Borrowings 8,170 19,335 Lease liabilities 5,850 5,982 Trade payables 2,136 2,593 Other financial liabilities 3,059 6,587 Deferred tax liabilities (net) 4,279 4,710 Other Liabilities 3,653 3,004 Total Liabilities 110,507 106,642 ❖ Increase in Goodwill and Intangible driven by BroadPath acquisition ❖ Intangibles of $16.5M created as a result of BroadPath acquisition ❖ DSO (excl. BroadPath) of 79 days in Mar’25 against 85 days in Mar’24. ❖ Borrowings (Promoter Debt) reduction due to conversion of loan into equity (in May’24) and repayment of debt. ❖ Reduction in Other financial liabilities pertains to pending purchase consideration paid towards for healthcare business carveout in Jan 22
Page 16
Cash Flow – FY25 16 Amt in INR M Particulars FY’25 FY'24 Profit before tax for the period/ year 7,602 2,417 Adjustment for Non-Operating and Non-Cash items 6,982 8,693 Adjustment for working capital (710) (114) Income taxes paid (net of refunds) (1,734) (1,263) Net cash flows generated from operating activities (A) - OCF 12,141 9,733 Addition to Fixed Assets (1,244) (1,827) Free Cash flow (FCF) 10,896 7,905 Cash paid for M&A (BroadPath) (4,825) (3,010) Pending Purchase consideration paid for healthcare business carveout (3,756) Others* 184 147 Net cash flows (used in) investing activities (B) (9,642) (4,691) Capital infused by promoter 3,708 0 IPO expense reimbursed 72 (72) Repayment of borrowings and lease liabilities (5,021) (5,546) Interest paid on borrowings and lease liabilities (1,320) (1,896) Net cash flows (used in) financing activities (C) (2,561) (7,513) Net increase/ (decrease) in cash and cash equivalents (A+B+C) (62) (2,471) Cash and cash equivalents at the beginning of the year/period 3,441 5,853 Effect of movement in exchange rates on cash and cash equivalents 58 60 Cash and cash equivalents at the end of the year/ period 3,438 3,441 Net cash flows generated from operating activities % (OCF on Reported EBITDA) 89.7% 87.2% Free Cash flow % (FCF on EBITDA) 80.5% 70.8% ❖ Non-Cash/Non-Operating Items includes Depreciation, Interest expenses, SAR, Unrealized Fx loss and Interest income ❖ Others include Proceeds from sale of fixed assets, Interest income and Proceeds from maturity of derivative assets/liabilities, (net)
Page 17
Thank You